UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 11, 2005
CORAUTUS GENETICS INC. |
(Exact Name Of Registrant As Specified In Charter) |
Delaware | | 0-27264 | | 33-0687976 |
(State of Incorporation) | | (Commission File No.) | | (I.R.S. Employer Identification No.) |
75 Fifth Street, NW
Suite 313
Atlanta, Georgia 30308
(Address of principal executive offices, including zip code)
(404) 526-6200
(Registrant’s telephone number, including area code)
Not applicable
(Former name or address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e(4)(c)) |
| |
|
Item 2.02. Results of Operations and Financial Condition.
On August 11, 2005, Corautus Genetics Inc. (“Corautus”) reported an update of its therapeutic development program and financial results for the three and six months ended June 30, 2005. A copy of Corautus’ press release announcing such is attached as Exhibit 99.1 hereto and incorporated herein by reference.
The information in the preceding paragraph, as well as Exhibit 99.1 referenced therein, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as otherwise expressly stated in such filing.
Item 9.01. Financial Statement and Exhibits
(c) Exhibits
Exhibit No. | | Description |
| |
|
99.1 | – | Press Release dated August 11, 2005 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CORAUTUS GENETICS INC. |
| (Registrant) |
| |
Date: August 11, 2005 | /s/ JACK W. CALLICUTT |
|
|
| Jack W. Callicutt |
| Vice President - Finance and Administration |
| Chief Accounting Officer |
Exhibit Index
Exhibit No. | | Description |
| |
|
99.1 | – | Press Release dated August 11, 2005 |
